Healthcare Supplies

AbbVie (ABBV) acquires Cerevel, enhancing its drug portfolio and opening new growth avenues in neuroscience for investors in ABBV stock.

Bayer's legal and pharmaceutical setbacks are something investors should pay attention to. These issues could impact BAYRY stock value and guide...

Explore the McKinsey Helix Report and discover insights into the future success of the biopharmaceutical industry.

The week ahead's IPOs previewed here are bioAffinity Technologies (NASDAQ: BIAF), Hempacco (NASDAQ: HPCO) and Wearable Devices (NASDAQ: WLDS).

After a short-lived rally, the Figs (NYSE: FIGS) stock price dips. Is FIGS stock a good long-term investment?

Hearing aid company Eargo Inc (NASDAQ: EAR) has seen its share price soar in the latest chapter of a topsy turvy year for the business. But is EAR...

The healthcare industry is fighting back against the world's top killer diseases, aiming to prolong lives and provide better standards of care for...

Bausch + Lomb is about to go public with an IPO, so we're taking a look at the stock to see if there's a clear case for investing.

Sierra Oncology (NASDAQ: SRRA) shares leapt by more than 25% on Wednesday after a breakthrough in the firm's quest to commercialize a blood cancer...

Shroom stocks are increasingly popular and the upside potential is huge. Here's an overview of the sector and a list of stocks available.

Pfizer offers a lot more to shareholders than a boost from COVID-19 vaccine revenues. With growth potential ahead, it may be undervalued.